|
⚲
|
| Keyboard |
| BridgeBio Oncology Therapeutics Inc
✚
|
|
|---|---|
| CIK # | 0001869105 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001869105] | |
| 10-Q | [0001869105] | |
| 3 | [0001869105] | |
| 4 | [0001869105] | |
| 8-K | [0001869105] | |
| SC 13D | [0001869105] | |
| SC 13G | [0001869105] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| BridgeBio Oncology Therapeutics Inc | |
| Beltran Pedro | |
| Ben Yong | |
| Elmelech Idan | |
| Cobo Marc | |
| Chen Bihua | |
| Kelleher Raymond J | |
| Lebowitz Peter F | |
| McCormick Frank | |
| Tipirneni Praveen P | |
| View All | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
BridgeBio Oncology Therapeutics Inc BBOT
Stock Option (Right to Buy) · derivative
|
2026-03-24 | Grant | 63,350 | $0.00 | |
|
BridgeBio Oncology Therapeutics Inc BBOT
Common Stock
|
2026-03-10 | Grant | 23,330 | $0.00 | |
|
BridgeBio Oncology Therapeutics Inc BBOT
Stock Option (Right to Buy) · derivative
|
2026-03-10 | Grant | 210,000 | $0.00 | |
|
BridgeBio Oncology Therapeutics Inc BBOT
Common Stock
|
2026-03-10 | Grant | 46,670 | $0.00 | |
|
BridgeBio Oncology Therapeutics Inc BBOT
Common Stock
|
2026-03-10 | Grant | 46,670 | $0.00 | |
|
BridgeBio Oncology Therapeutics Inc BBOT
Stock Option (Right to Buy) · derivative
|
2026-03-10 | Grant | 105,000 | $0.00 | |
|
BridgeBio Oncology Therapeutics Inc BBOT
Stock Option (Right to Buy) · derivative
|
2026-03-10 | Grant | 210,000 | $0.00 | |
|
BridgeBio Oncology Therapeutics Inc BBOT
Stock Option (Right to Buy) · derivative
|
2026-01-01 | Grant | 1,114,400 | $0.00 | |
|
BridgeBio Oncology Therapeutics Inc BBOT
Stock Option (Right to Buy) · derivative
|
2025-12-10 | Disposed to issuer | 1,114,400 | ||
|
BridgeBio Oncology Therapeutics Inc BBOT
Common Stock
|
2025-10-10 | Other | 784,720 | ||
|
BridgeBio Oncology Therapeutics Inc BBOT
Stock Option (Right to Buy) · derivative
|
2025-10-02 | Grant | 1,614,400 | $0.00 | |
|
BridgeBio Oncology Therapeutics Inc BBOT
Class B ordinary shares · derivative
|
2025-08-11 | Disposed to issuer | 307,874 | $0.00 | |
|
BridgeBio Oncology Therapeutics Inc BBOT
Class B ordinary shares · derivative
|
2025-08-11 | Option exercise | 4,172,126 | ||
|
BridgeBio Oncology Therapeutics Inc BBOT
Class B ordinary shares · derivative
|
2025-08-11 | Option exercise | 30,000 | $0.00 | |
|
BridgeBio Oncology Therapeutics Inc BBOT
Class B ordinary shares · derivative
|
2025-08-11 | Option exercise | 30,000 | $0.00 | |
|
BridgeBio Oncology Therapeutics Inc BBOT
Class B ordinary shares · derivative
|
2025-08-11 | Option exercise | 30,000 | $0.00 | |
|
BridgeBio Oncology Therapeutics Inc BBOT
Common Stock
|
2025-08-11 | Grant | 5,598,425 | $10.72 | 60,015,116 |
|
BridgeBio Oncology Therapeutics Inc BBOT
Common Stock
|
2025-08-11 | Disposed to issuer | 152,940 | $0.00 | |
|
BridgeBio Oncology Therapeutics Inc BBOT
Common Stock
|
2025-08-11 | Option exercise | 4,172,126 | ||
|
BridgeBio Oncology Therapeutics Inc BBOT
Common Stock
|
2025-08-11 | Grant | 760,496 | $10.72 | 8,152,517 |
| showing 20 of 34 most recent transactions | |||||